临床外科杂志 ›› 2025, Vol. 33 ›› Issue (10): 1077-1081.doi: 10.3969/j.issn.1005-6483.20241574

• 论著 • 上一篇    下一篇

血清长链非编码RNA Kinectin 1反义RNA 1和视网膜母细胞瘤结合蛋白4表达与食管癌病人术后复发转移的关系

衣舜 柳爽爽 王耀鹏 王传孝 矫文捷   

  1. 266000 山东青岛,青岛大学附属医院胸外科(衣舜、矫文捷),儿科(柳爽爽);青岛市市立医院胸外科(衣舜、王耀鹏、王传孝)
  • 收稿日期:2024-09-27 出版日期:2025-11-11 发布日期:2025-11-11
  • 通讯作者: 矫文捷,Email:xxm86s@163.com

The relationship between the expression of long chain non coding RNA Kinectin 1 antisense RNA 1 and retinoblastoma binding protein 4 with postoperative recurrence and metastasis in esophageal cancer patients

YI Shun*,LIU Shuangshuang,WANG Yaopeng,WANG Chuanxiao,JIAO Wenjie   

  1. *Department of Thoracic Surgery,Affiliated Hospital of Qingdao University,Shandong,Qingdao 266000,China
  • Received:2024-09-27 Online:2025-11-11 Published:2025-11-11

摘要: 目的 探讨血清长链非编码RNA Kinectin 1反义RNA 1(LncRNA KTN1-AS1)和视网膜母细胞瘤结合蛋白4(RBBP4)表达水平与食管癌病人术后复发转移的关系。方法 2018年5月~2021年5月行手术治疗的食管癌病人119例作为研究组,随访3年,根据是否复发转移将其分为发生组(51例)和未发生组(68例)。另选取同一阶段治疗的食管良性肿瘤病人100例为对照组。运用ELISA法检测血清LncRNA KTN1-AS1、RBBP4水平;食管癌病人术后复发转移的影响因素用多因素Logistic回归分析;ROC曲线分析血清RBBP4、LncRNA KTN1-AS1对食管癌病人术后复发转移的预测价值。结果 研究组血清LncRNA KTN1-AS1、RBBP4表达水平高于对照组,差异有统计学意义(P<0.05);发生组血清LncRNA KTN1-AS1、RBBP4表达水平及浸润深度黏膜/黏膜下层占比、低分化程度占比、淋巴结转移占比明显高于未发生组,差异有统计学意义(P<0.05);血清LncRNA KTN1-AS1、RBBP4、淋巴结转移、分化程度、浸润深度是食管癌病人术后复发转移的影响因素(P<0.05);血清LncRNA KTN1-AS1、RBBP4联合预测食管癌病人术后复发转移的曲线下面积(AUC)为0.912,优于各自单独预测(Z二者联合-LncRNA KTN1-AS1=2.470、Z二者联合-RBBP4=1.994,P=0.014、P=0.046),其联合预测的敏感度、特异度分别为90.20%、85.29%。结论 食管癌病人血清LncRNA KTN1-AS1、RBBP4表达水平均显著升高,其与病人术后复发转移有着紧密联系,二者联合检测对病人术后复发转移有较好的预测价值。

关键词: 食管癌, 长链非编码RNA Kinectin 1反义RNA 1, 视网膜母细胞瘤结合蛋白4, 复发, 转移

Abstract: Objective To explore the relationship between the expression levels of serum long chain non coding RNA Kinectin 1 antisense RNA 1 (LncRNA KTN1-AS1) and retinoblastoma binding protein 4 (RBBP4) with postoperative recurrence and metastasis in esophageal cancer patients.Methods From May 2018 to May 2021,119 patients with esophageal cancer who underwent surgical treatment in our hospital were included as the study group.They were separated into an occurrence group (n=51) and a non occurrence group (n=68) based on whether there was recurrence or metastasis during a 3-year follow-up.Additionally,100 patients with benign esophageal tumors treated at the same stage were selected as the control group.ELISA method was applied to detect the expression levels of serum LncRNA KTN1-AS1 and RBBP4.Multivariate Logistic regression was applied to analyze the influencing factors of postoperative recurrence and metastasis in esophageal cancer patients.ROC curve was applied to analyze the predictive value of serum LncRNA KTN1-AS1 and RBBP4 for postoperative recurrence and metastasis in esophageal cancer patients.Results The expression levels of serum LncRNA KTN1-AS1 and RBBP4 in the study group were obviously higher than those in the control group (P<0.05).The expression levels of serum LncRNA KTN1-AS1 and RBBP4,and the proportions of mucosal/submucosal infiltration depth,and low differentiation degree and proportion of lymph node metastasis in the occurrence group were obviously higher than those in the non occurrence group (P<0.05).Serum LncRNA KTN1-AS1,RBBP4,proportion of lymph node metastasis,degree of differentiation,and depth of infiltration were influencing factors for postoperative recurrence and metastasis in esophageal cancer patients (P<0.05).The area under the curve (AUC) of the combined prediction of serum LncRNA KTN1 AS1 and RBBP4 for postoperative recurrence and metastasis in esophageal cancer patients was 0.912,which was better than their individual predictions (Zcombination-LncRNA KTN1 AS1=2.470,Zcombination-RBBP4=1.994,P=0.014,P=0.046),the sensitivity and specificity of the combined prediction were 90.20% and 85.29%,respectively.Conclusion The expression levels of serum LncRNA KTN1-AS1 and RBBP4 in esophageal cancer patients are obviously increased,which is closely related to postoperative recurrence and metastasis.The combined detection of the two has good predictive value for postoperative recurrence and metastasis in patients.

Key words: esophageal cancer, long chain non coding RNA Kinectin 1 antisense RNA 1, retinoblastoma binding protein 4, recurrence, metastasis

[1] 侯英利 冯晓娜 李春晖 侯永超 殷星. 食管癌病人血清lncRNA CASC11、lncRNA THOR表达水平及其临床意义[J]. 临床外科杂志, 2025, 33(9): 969-973.
[2] 袁双龙 刘秀军 贾立周. 巨大滤泡状甲状腺癌伴甲亢及多处转移一例[J]. 临床外科杂志, 2025, 33(9): 1007-1008.
[3] 黄志刚 张兴伟 张宇 邹青旭. N-乙酰转移酶10、丝氨酸羟甲基转移酶 2、YTHN6-甲基腺苷RNA结合蛋白1在肺癌组织中的表达及与临床病理特征、预后的相关性[J]. 临床外科杂志, 2025, 33(8): 827-831.
[4] 汪俊 吕瑕智 陶玉 胡传朋. 血清微小核糖核酸-335-5p、内皮细胞特异性分子-1对食管癌病人的早期诊断及预后评估价值[J]. 临床外科杂志, 2025, 33(8): 836-840.
[5] 邹裕海 刘雨 梁必雄. 术前呼吸道准备与术后引流量对食管癌胸腹腔镜根治术后肺部并发症的影响[J]. 临床外科杂志, 2025, 33(8): 841-845.
[6] 孙岩 王政 刘全达. 肝动脉灌注化疗治疗结直肠癌肝转移[J]. 临床外科杂志, 2025, 33(8): 887-889.
[7] 张智 张青青 温艳娜 屈少磊. 食管癌根治术后并发肺部感染病人病原菌分布及血清人β-防御素-3、FMS样酪氨酸激酶3配体水平变化[J]. 临床外科杂志, 2025, 33(6): 602-606.
[8] 李永 汪鸿波 李雷. 结直肠癌组织微小核糖核酸-30c-5p、非酶几丁质酶-3样蛋白-1表达及与其临床病理特征、淋巴结转移的关系[J]. 临床外科杂志, 2025, 33(6): 628-631.
[9] 贠宇辉 姬翔 韩国梁 郭伟. 食管癌胸腔镜根治术中不同喉返神经旁淋巴结清扫对近期疗效、血清髓系细胞触发受体-1、肿瘤坏死因子受体相关蛋白-1水平及生存质量的影响[J]. 临床外科杂志, 2025, 33(5): 482-485.
[10] 杨三虎 李岩 黄立军 颜振科 刘旭 李万山 姬翔. 早中期食管癌全腔镜切除术后3年无复发生存的随机森林预测研究[J]. 临床外科杂志, 2025, 33(5): 486-492.
[11] 卢海 付琴 朱允和 张先政. 咪达唑仑调节CCL2-CCR2信号通路对食管癌细胞增殖、迁移和侵袭的影响[J]. 临床外科杂志, 2025, 33(5): 493-497.
[12] 隋晓军 杨磊 徐新生 张大鹏. 胆囊神经内分泌癌伴腹膜转移一例[J]. 临床外科杂志, 2025, 33(5): 556-557.
[13] 彭向向, 郑青松, 门东海. 三阴性男性隐匿性乳腺癌脑转移一例[J]. 临床外科杂志, 2025, 33(4): 391-392.
[14] 彭伟生, 杨毅, 杨翠婷, 王成立, 何桂凤, 郑宇强, 黄莹. 基于增强CT影像组学特征和参数诊断胃腺癌术前淋巴结转移的列线图预测模型[J]. 临床外科杂志, 2025, 33(4): 405-409.
[15] 潘均昊, 王春晖. 基于SEER数据库构建远处转移性肝细胞癌的预后预测模型[J]. 临床外科杂志, 2025, 33(4): 410-415.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!